{"text": "bmy blue bristol myers resubmits cancer cell therapy lifting investors chance at payout via"}
{"text": "bmy short interest ratio on 2019 05 31 is 7 48 pfe 2 86 lly 2 61 jnj 1 87"}
{"text": "hey jim whats up with bmy rated a 1 but going nowhere does it really have a future or can those dollars be put to better use"}
{"text": "bmy bristol myers and bluebird bio blue announce submission of bla for ide cel for adults with relapsed and"}
{"text": "bristol myers resubmits cancer cell therapy lifting investors chance at payout bmy blue"}
{"text": "a surprise refusal by the fda in may to review bmy s application had put at risk a conditional payment promised as part of the pharma s celg deal"}
